Amanote Research
Register
Sign In
Human Recombinant RNASET2: A Potential Anti-Cancer Drug
Oncoscience
- United States
doi 10.18632/oncoscience.295
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
March 4, 2016
Authors
Unknown
Publisher
Impact Journals, LLC
Related search
Arsenic Sulfide as a Potential Anti-Cancer Drug
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Ellagic Acid as a Potential Anti-Cancer Drug
International Journal of Radiology & Radiation Therapy
Molecular Characteristics of Multicorn, a New Large Proteolytic Assembly and Potential Anti-Cancer Drug Target, in Human Breast Cancer Cells
Phycocyanin: A Potential Drug for Cancer Treatment
Journal of Cancer
Oncology
RNASET2 Silencing Affects miRNAs and Target Gene Expression Pattern in a Human Ovarian Cancer Cell Model
International Journal of Oncology
Cancer Research
Oncology
A FRET-based Biosensor for Targeting the hNTH1-YB1 Interface as a Potential Anti-Cancer Drug Target
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
Drug Interaction (27. Anti-Emetics During Anti-Cancer Chemotherapy)
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Dual Anti‐vascular Function of Human Fibulin‐3 Variant, a Potential New Drug Discovery Strategy for Glioblastoma
Cancer Science
Cancer Research
Medicine
Oncology
mTOR Mediated Anti-Cancer Drug Discovery
Drug Discovery Today: Therapeutic Strategies
